Literature DB >> 34006939

From multi-omics integration towards novel genomic interaction networks to identify key cancer cell line characteristics.

T J M Kuijpers1, J C S Kleinjans2, D G J Jennen2.   

Abstract

Cancer is a complex disease where cancer cells express epigenetic and transcriptomic mechanisms to promote tumor initiation, progression, and survival. To extract relevant features from the 2019 Cancer Cell Line Encyclopedia (CCLE), a multi-layer nonnegative matrix factorization approach is used. We used relevant feature genes and DNA promoter regions to construct genomic interaction network to study gene-gene and gene-DNA promoter methylation relationships. Here, we identified a set of gene transcripts and methylated DNA promoter regions for different clusters, including one homogeneous lymphoid neoplasms cluster. In this cluster, we found different methylated transcription factors that affect transcriptional activation of EGFR and downstream interactions. Furthermore, the hippo-signaling pathway might not function properly because of DNA hypermethylation and low gene expression of both LATS2 and YAP1. Finally, we could identify a potential dysregulation of the CD28-CD86-CTLA4 axis. Characterizing the interaction of the epigenome and the transcriptome is vital for our understanding of cancer cell line behavior, not only for deepening insights into cancer-related processes but also for future disease treatment and drug development. Here we have identified potential candidates that characterize cancer cell lines, which give insight into the development and progression of cancers.

Entities:  

Year:  2021        PMID: 34006939     DOI: 10.1038/s41598-021-90047-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  44 in total

Review 1.  Epigenetic changes of DNA repair genes in cancer.

Authors:  Christoph Lahtz; Gerd P Pfeifer
Journal:  J Mol Cell Biol       Date:  2011-02       Impact factor: 6.216

Review 2.  Oncogenes and cancer.

Authors:  Carlo M Croce
Journal:  N Engl J Med       Date:  2008-01-31       Impact factor: 91.245

3.  Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

Authors:  M Esteller; J M Silva; G Dominguez; F Bonilla; X Matias-Guiu; E Lerma; E Bussaglia; J Prat; I C Harkes; E A Repasky; E Gabrielson; M Schutte; S B Baylin; J G Herman
Journal:  J Natl Cancer Inst       Date:  2000-04-05       Impact factor: 13.506

4.  Role of Rb family in the epigenetic definition of chromatin.

Authors:  Susana Gonzalo; María A Blasco
Journal:  Cell Cycle       Date:  2005-06-08       Impact factor: 4.534

Review 5.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

Review 6.  Expression genetics in cancer: shifting the focus from DNA to RNA.

Authors:  R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

Review 7.  Oncogenes and tumor suppressor genes.

Authors:  Eva Y H P Lee; William J Muller
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-18       Impact factor: 10.005

Review 8.  Genomic Instability in Cancer: Teetering on the Limit of Tolerance.

Authors:  Noemi Andor; Carlo C Maley; Hanlee P Ji
Journal:  Cancer Res       Date:  2017-04-21       Impact factor: 12.701

9.  Cancer. Addiction to oncogenes--the Achilles heal of cancer.

Authors:  I Bernard Weinstein
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

Review 10.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.